DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/fg6ftp/research_report_on) has announced the addition of the "Research Report on China's Antihypertensive Medicine Market, 2012" report to their offering.

In recent years, with Chinese people's living standards continuously improving and elderly people increasing, prevalence rate of hypertension incessantly rises. Presently, there's still no effective means to cure hypertension. According to the WHO statistics about death of various diseases, death toll of cardiovascular disease which is represented by hypertension increases from 28.8% of the total mortality toll in 1997 to 36.0% in 2002. Hypertension is a serious danger to human health.

According to a press release issued by the International Society of Hypertension, the number of global hypertension or abnormally high blood pressure crowds reaches 972 million, accounting for 26.4% of the world's adult population. With the invention and application of CCB, ACEI, ARB and other new-generation antihypertensive medicines, the mortality rate of various cardiovascular diseases sharply declines. Nevertheless, there are still 17 million people across the world die from cardiovascular and cerebrovascular diseases caused by hypertension and half of them die from acute myocardial infarction and cerebrovascular embolism. So people pay high attention to antihypertensive medicine market.

More following information can be acquired through this report:

- China's Hypertensive Attack Situation

- Current Market of China's Antihypertensive Medicine

- Development Trend of China's Antihypertensive Medicine

Following people are recommended to buy this report:

- Pharmaceutical Enterprises

Go here to read the rest:

Research and Markets: Research Report on China's Antihypertensive Medicine Market, 2012